Browsing by Subject "Enrollment"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item An Analysis of Subject Recruitment Issues for an HCV Investigational Drug Clinical Trial(2009-05-01) Lander, Aitemad A.; Oglesby, MichaelChronic hepatitis C infection is debilitating, and investigational drugs currently in phase III clinical trials are promising. It is important that efficient antiviral medication reach market if it has the potential for inhibiting viral replication. Because of subject recruitment issues, many studies fail to meet enrollment goals and therefore cannot complete the clinical trial process and bring drugs to market. Therefore, a recruitment plan must be implemented that will ensure that enrollment goals are met. The goal of this practicum was to test the hypothesis that educating the medical and non-medical community about the HCV clinical trials would increase subject enrollment. However, due to certain limitations, not enough data was gathered to provide clear and concise results.Item Identifying barriers to enrollment and strategies to increase enrollment at a community-based cancer treatment center(2014-05-01) Gokul, Sheila R.; Ladislav DoryAlthough clinical trials are essential for the development of cancer treatments, only approximately 3% of cancer patients in the U.S. participate in them. While 55% of these patients are enrolled in cancer clinical trials through community-based practices and around 80% of all cancer patients are seen at this type of practice, there is a lack of knowledge about the enrollment barriers at these sites. This study evaluates enrollment barriers at a community-based cancer clinic at the levels of the investigative site, healthcare provider, and patient. Barriers to enrollment and strategies to increase enrollment are evaluated through historical data analyses and results from a survey assessing the opinions of healthcare providers on enrollment and research practices.